• Saturday, May 28, 2022
  • Last Update : 04:24 pm

Globe Biotech yet to get BMRC nod for human trials

  • Published at 09:58 pm February 22nd, 2021
covid-19 vaccine
Representational image Bigstock

A decision regarding this to be made soon, say officials

Globe Biotech Limited, the only Bangladeshi company that is trying to develop a Covid-19 vaccine in the country, is yet to get ethical permission for conducting human trials.

The company had submitted a protocol to the Bangladesh Medical Research Council (BMRC) for ethical approval to conduct the clinical trial of its vaccine – Bangavax – on January 17. 

Although more than a month has since passed, the BMRC is yet to give approval for human trials for the homegrown vaccine on the explanation that such procedures take time.

However, officials at the council claimed that they were trying to finish everything within the shortest possible time.

High officials of Globe Biotech have said that despite all the delays, they were hopeful of completing at least two trial phases of their vaccine and launch it after June this year.

Talking to Dhaka Tribune, Globe Biotech Chairman Md Harunur Rashid said that the firm’s primary target, to get vaccine production started early this year, could not be attained due to several factors.

“But now we are on the right track. As far as we have been informed the [BMRC] review committee has given the clearance that we needed and it will be announced soon,” he said. 

Also Read - Covid-19: Daily test positivity rate rises above 3% again in Bangladesh

“We are hoping to start trials within March and after that’s done, we want to go for production after June,” the Globe Biotech boss added.   

The BMRC National Research Ethics Committee Chairman, National Professor Dr Shahla Khatun, said it would be “unwise” to disclose information related to an ongoing process.

Dr Shahla Khatun also pointed out that the BMRC would only provide “ethical permission” for human trials. “It is the government which will finally decide whether or not Globe Biotech will be allowed to conduct trials,” she said.

“A decision regarding the issue will be announced soon,” she added.  

Meanwhile, Cabinet Secretary Khandker Anwarul Islam, after a weekly virtual meeting of the Cabinet Division on Monday, said that the Globe Biotech issue was discussed at the meeting.

Also Read - News Analysis: Vaccine management so far so good

“Globe Biotech is yet to conduct its trials. If it is allowed to do so, in line with WHO protocol, we will see what can be done,” he added.

Earlier on December 28 last year, the Directorate General of Drug Administration (DGDA) permitted Globe Biotech to manufacture Bangavax for clinical trials.

On December 1, Globe Biotech announced that it would part ways with the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) on conducting human trials of its vaccine.

Globe Biotech cancelled the memorandum of understanding (MoU) as it had observed limited progress in icddr,b's approach to conducting the human trials

On July 2, claiming success in preliminary animal modelling trials for the Covid-19 vaccine, Globe Biotech claimed to be the first company from Bangladesh to have a Covid-19 vaccine under development.

It obtained the result after conducting preliminary trials on five rabbits from June 10 to June 28, said Dr Asif Mahmud, assistant manager and in-charge, Research and Development, Globe Biotech Limited at a press conference.

Facebook 50
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail